• Tropisetron Hydrochloride: Precision in 5-HT3 Receptor Antag

  2026-07-21

  Tropisetron Hydrochloride empowers researchers with dual 5-HT3/α7-nicotinic modulation and robust, reproducible performance in neuroscience and renal transporter assays. Unlock advanced troubleshooting strategies and workflow enhancements with APExBIO’s high-purity compound for translational receptor signaling research.

• Hexetidine (NSC-17764): Translational Insights for Oral Infe

  2026-07-20

  This thought-leadership article bridges molecular mechanisms, experimental protocols, and translational strategy for deploying Hexetidine (NSC-17764) in oral infection research. Designed for translational scientists, it contextualizes recent evidence on biofilm disruption, competitive positioning versus chlorhexidine, and best practices for protocol integration, culminating in actionable future-facing guidance.

• DPPH Radical Assay: Applied Workflows for Antioxidant Screen

  2026-07-20

  Harness the DPPH (2,2-Diphenyl-1-Picrylhydrazyl) Radical for robust, reproducible in vitro antioxidant assays—even with complex natural extracts. This guide delivers stepwise workflow enhancements, troubleshooting strategies, and insights from comparative studies, ensuring maximum assay performance for high-throughput antioxidant screening and natural product evaluation.

• Methicillin Sodium Salt: Optimizing Infection Models & Assay

  2026-07-19

  Methicillin sodium salt remains the benchmark compound for modeling Staphylococcus aureus susceptibility and resistance in translational research. This guide details robust experimental workflows, data-driven parameterization, and troubleshooting strategies to maximize the reliability and interpretability of your bacterial cell wall synthesis assays.

• Standardized Amplex Red Assay for Autotaxin Inhibitor Screen

  2026-07-18

  Stylianaki et al. present a rigorously validated, fluorescence-based microplate protocol using Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) to quantify the efficacy and kinetics of autotaxin (ATX) inhibitors. This standardized workflow enables high-throughput, reproducible assessment of candidate compounds and provides a robust platform for drug discovery targeting ATX-mediated pathologies.

• Ceftolozane Sulfate: Applied Workflows in Antibacterial Rese

  2026-07-17

  Ceftolozane sulfate accelerates robust, resistance-aware antibacterial research, especially against Pseudomonas aeruginosa. This article delivers actionable experimental workflows, advanced troubleshooting, and translational insights rooted in the latest PK/PD and susceptibility assay innovations.

• Dissecting P. aeruginosa Resistance: ampC/ampD Mutations and

  2026-07-17

  This study provides a quantitative analysis of how ampC and ampD mutations in Pseudomonas aeruginosa drive resistance to ceftolozane-tazobactam, utilizing semi-mechanistic PKPD modeling to distinguish between acquired and adaptive resistance. The methods and findings offer a robust framework for future research into resistance mechanisms and inform the development of experimental infection models.

• Deferoxamine Mesylate in Ferroptosis and Hypoxia Signaling R

  2026-07-16

  Explore the multifaceted utility of Deferoxamine mesylate as an iron-chelating agent in advanced cancer and hypoxia research. This article uniquely dissects its mechanistic role in ferroptosis modulation and HIF-1α stabilization, bridging emerging findings and practical workflows.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Lab G

  2026-07-16

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is formulated to prevent protein degradation during extraction and analysis, especially in workflows sensitive to divalent cations. It is best applied in Western blotting, co-immunoprecipitation, and phosphorylation studies; it should not be used for workflows that require metalloprotease inhibition via chelation.

• Acetylcysteine: Mechanisms, Evidence & Research Applications

  2026-07-15

  Acetylcysteine (N-acetyl-L-cysteine) is an antioxidant precursor for glutathione biosynthesis with proven mucolytic and cytoprotective effects. This article systematically details its mechanistic roles, evidence base, and experimental parameters for oxidative stress pathway modulation and disease modeling.

• Novobiocin: Mechanistic Insight and Translational Strategy

  2026-07-15

  This thought-leadership article explores Novobiocin’s dual mechanisms—bacterial DNA gyrase inhibition and Hsp90 modulation—offering translational researchers evidence-driven guidance for tackling antibacterial resistance, antiparasitic, and antiviral challenges. We contextualize APExBIO’s Novobiocin (BA1116) within a competitive landscape, highlight protocol best practices, and provide a visionary outlook rooted in robust mechanistic data and synergistic strategies.

• Cefiderocol vs. β-Lactam/β-Lactamase Inhibitors in MDR P. ae

  2026-07-14

  This study provides a robust in vitro comparison of cefiderocol and contemporary β-lactam/β-lactamase inhibitor combinations against European isolates of Pseudomonas aeruginosa and Acinetobacter spp., including those with significant carbapenem resistance. Its findings clarify cefiderocol's potent activity where other agents—including ceftolozane-tazobactam—often fail, informing both clinical decision-making and laboratory assay design.

• Lisinopril Dihydrate in Translational Vascular Research: Sel

  2026-07-14

  Explore the nuanced selectivity and mechanistic impact of Lisinopril dihydrate, a potent ACE inhibitor, in vascular and hypertension research. This article uniquely dissects practical assay design, reference-based selectivity, and advanced research applications.

• Gamithromycin (BA1074): Novel Insights for Pathogen-Specific

  2026-07-13

  Explore advanced, evidence-driven applications of Gamithromycin (ML-1709460) in pathogen susceptibility assays and veterinary disease modeling. This article delivers unique, practical analysis for optimizing antibacterial protocols—grounded in cutting-edge reference data and distinct from standard protocol reviews.

• Thymoquinone Counters Doxorubicin Cardiotoxicity via Nrf2/HO

  2026-07-13

  This study reveals that thymoquinone, a phytochemical from Nigella sativa, protects mouse cardiomyocytes from doxorubicin-induced toxicity by activating the Nrf2/HO-1 pathway and alleviating ferroptosis. These findings highlight thymoquinone's value as a mechanistic probe for dissecting oxidative and iron-mediated cardiac injury.

456 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page